Exp: 04/26 Original price was: 4,980.Current price is: 2,980
Dopaminergic dysfunction and glucose metabolism characteristics in parkin-induced early-onset Parkinsons disease compared to genetically undetermined early-onset Parkinsons disease
Semaglutide 2.4mg (Wegovy) is commissioned by the NHS only through specialist weight management services, with specific eligibility criteria (including BMI thresholds, which are lower for people from some ethnic groups) and a maximum treatment duration of 2 years
Cyclic changes in phospholipid content and composition in human endometrium during the menstrual cycle
We found increased serum IGF1R levels in our NSCLC patient cohort
This compound is being explored in research settings for its potential impact on conditions associated with energy metabolism, insulin sensitivity, and body composition